Latest & greatest articles for atrial fibrillation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on atrial fibrillation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on atrial fibrillation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for atrial fibrillation

281. Atrial Fibrillation ? Diagnosis and Management

Atrial Fibrillation ? Diagnosis and Management Guidelines & Protocols Advisory Committee Atrial Fibrillation – Diagnosis and Management Effective Date: April 1, 2015 Scope This guideline provides recommendations for the diagnosis and management of atrial fibrillation (AF) including the primary prevention of stroke and transient ischemic attack (TIA) in adults aged =19 years. This guideline focuses primarily on non-valvular AF . This guideline is part of the BCGuidelines.ca – Stroke and (...) Atrial Fibrillation series. The series includes three other guidelines: Stroke and Transient Ischemic Attack – Acute and Long-Term Management; Use of Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) in Non-Valvular Atrial Fibrillation; and Warfarin Therapy Management. Key Recommendations • Determine the patient’s cardiac stability and provide emergency stabilization if needed. • Consider all patients with atrial fibrillation for antithrombotic therapy (short and long term). • Establish the risk of stroke in

Clinical Practice Guidelines and Protocols in British Columbia2015

283. Monitoring for Atrial Fibrillation in Discharged Stroke and Transient Ischemic Attack Patients

Monitoring for Atrial Fibrillation in Discharged Stroke and Transient Ischemic Attack Patients Monitoring for Atrial Fibrillation in Discharged Stroke and Transient Ischemic Attack Patients | CADTH.ca Find the information you need Monitoring for Atrial Fibrillation in Discharged Stroke and Transient Ischemic Attack Patients Monitoring for Atrial Fibrillation in Discharged Stroke and Transient Ischemic Attack Patients Published on: September 14, 2015 Project Number: OP0523 Product Line: Result (...) type: Report CADTH undertook a health technology assessment (HTA) to inform decision-making about the appropriate use of monitoring for atrial fibrillation (AF) in discharged stroke and transient ischemic attack (TIA) patients. The HTA addressed the clinical and cost-effectiveness of AF ambulatory monitoring devices in outpatient stroke and TIA patients, and identified patient perspectives regarding the value and impact of the AF monitoring devices on their health, health care, and quality

CADTH - Optimal Use2015

284. Monitoring for Atrial Fibrillation in Discharged Stroke and Transient Ischemic Attack Patients

Monitoring for Atrial Fibrillation in Discharged Stroke and Transient Ischemic Attack Patients Monitoring for Atrial Fibrillation in Discharged Stroke and Transient Ischemic Attack Patients | CADTH.ca Find the information you need Monitoring for Atrial Fibrillation in Discharged Stroke and Transient Ischemic Attack Patients Monitoring for Atrial Fibrillation in Discharged Stroke and Transient Ischemic Attack Patients Published on: September 14, 2015 Project Number: OP0523 Product Line: Result (...) type: Report CADTH undertook a health technology assessment (HTA) to inform decision-making about the appropriate use of monitoring for atrial fibrillation (AF) in discharged stroke and transient ischemic attack (TIA) patients. The HTA addressed the clinical and cost-effectiveness of AF ambulatory monitoring devices in outpatient stroke and TIA patients, and identified patient perspectives regarding the value and impact of the AF monitoring devices on their health, health care, and quality

CADTH - Optimal Use2015

285. Report in Brief - Optimal Warfarin Management for Prevention of Thromboembolic Events in Patients with Atrial Fibrillation

Report in Brief - Optimal Warfarin Management for Prevention of Thromboembolic Events in Patients with Atrial Fibrillation Warfarin Management for Thromboembolic Events in Atrial Fibrillation | CADTH.ca Find the information you need Warfarin Management for Thromboembolic Events in Atrial Fibrillation Warfarin Management for Thromboembolic Events in Atrial Fibrillation Published on: August 15, 2011 Project Number: OP0508 Product Line: Result type: Report Warfarin has been the mainstay of oral (...) anticoagulant therapy for more than 60 years. The effectiveness of warfarin for the prevention of stroke in patients with atrial fibrillation is well established. In Canada, an estimated 200,000 to 250,000 people have this condition. Need for Recommendations Managing warfarin therapy is challenging because warfarin interacts with many foods and other drugs. Each patient needs an individualized warfarin dose, which takes time to determine and requires patients to go in for frequent laboratory testing

CADTH - Optimal Use2015

286. Clinical efficacy of epicardial application of drug-releasing hydrogels to prevent postoperative atrial fibrillation

Clinical efficacy of epicardial application of drug-releasing hydrogels to prevent postoperative atrial fibrillation 26254755 2015 12 24 2016 04 25 2015 12 24 1097-685X 151 1 2016 Jan The Journal of thoracic and cardiovascular surgery J. Thorac. Cardiovasc. Surg. Clinical efficacy of epicardial application of drug-releasing hydrogels to prevent postoperative atrial fibrillation. 80-5 10.1016/j.jtcvs.2015.06.061 S0022-5223(15)01089-2 Postoperative atrial fibrillation is the most frequent (...) complication arising after cardiac surgery, occurring in 40% of cases. The treatment of postoperative atrial fibrillation with epicardial amiodarone/corticosteroid hydrogel delivery can increase efficacy and reduce side effects. To further evaluate whether amiodarone hydrogel is superior to corticosteroid hydrogel or placebo, we performed a randomized prospective study in 150 patients with coronary artery bypass grafting to compare the effectiveness with different epicardial drug approaches

EvidenceUpdates2015

287. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.

Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. IMPORTANCE: The CHA2DS2-VASc score (congestive heart failure, hypertension, age ≥75 years [doubled], diabetes, stroke/transient ischemic attack/thromboembolism [doubled], vascular disease [prior myocardial infarction, peripheral artery disease, or aortic plaque], age 65-75 years, sex category [female]) is used clinically for stroke (...) risk stratification in atrial fibrillation (AF). Its usefulness in a population of patients with heart failure (HF) is unclear. OBJECTIVE: To investigate whether CHA2DS2-VASc predicts ischemic stroke, thromboembolism, and death in a cohort of patients with HF with and without AF. DESIGN, SETTING, AND POPULATION: Nationwide prospective cohort study using Danish registries, including 42 987 patients (21.9% with concomitant AF) not receiving anticoagulation who were diagnosed as having incident HF

JAMA2015 Full Text: Link to full Text with Trip Pro

288. Catheter Ablation for Persistent Atrial Fibrillation.

Catheter Ablation for Persistent Atrial Fibrillation. Catheter Ablation for Persistent Atrial Fibrillation. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26308689 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Aug 27;373(9):878-9. doi: 10.1056/NEJMc1508689. Catheter Ablation for Persistent Atrial Fibrillation. , , . Comment on [N Engl J Med. 2015] [N Engl J Med. 2015] [N Engl J Med. 2015] [N Engl J Med. 2015] PMID: 26308689 DOI: [Indexed for MEDLINE] Free full text Publication types MeSH terms Full Text Sources Medical PubMed

NEJM2015

289. Catheter Ablation for Persistent Atrial Fibrillation.

Catheter Ablation for Persistent Atrial Fibrillation. Catheter Ablation for Persistent Atrial Fibrillation. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26308690 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Aug 27;373(9):877. doi: 10.1056/NEJMc1508689#SA1. Catheter Ablation for Persistent Atrial Fibrillation. , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26308690 DOI: [Indexed for MEDLINE] Publication types MeSH terms Full Text Sources Medical PubMed Commons 0 comments How to cite this comment

NEJM2015 Full Text: Link to full Text with Trip Pro

290. Catheter Ablation for Persistent Atrial Fibrillation.

Catheter Ablation for Persistent Atrial Fibrillation. Catheter Ablation for Persistent Atrial Fibrillation. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26308691 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Aug 27;373(9):877-8. doi: 10.1056/NEJMc1508689#SA2. Catheter Ablation for Persistent Atrial Fibrillation. , , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26308691 DOI: [Indexed for MEDLINE] Publication types MeSH terms Full Text Sources Medical PubMed Commons 0 comments How to cite this comment

NEJM2015 Full Text: Link to full Text with Trip Pro

291. Catheter Ablation for Persistent Atrial Fibrillation.

Catheter Ablation for Persistent Atrial Fibrillation. Catheter Ablation for Persistent Atrial Fibrillation. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26308692 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Aug 27;373(9):878. doi: 10.1056/NEJMc1508689#SA3. Catheter Ablation for Persistent Atrial Fibrillation. , , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26308692 DOI: [Indexed for MEDLINE] Publication types MeSH terms Full Text Sources Medical PubMed Commons 0 comments How to cite this comment

NEJM2015 Full Text: Link to full Text with Trip Pro

292. Warfarin Management for Thromboembolic Events in Atrial Fibrillation

Warfarin Management for Thromboembolic Events in Atrial Fibrillation Warfarin Management for Thromboembolic Events in Atrial Fibrillation | CADTH.ca Find the information you need Warfarin Management for Thromboembolic Events in Atrial Fibrillation Warfarin Management for Thromboembolic Events in Atrial Fibrillation Published on: August 15, 2011 Project Number: OP0508 Product Line: Result type: Report Warfarin has been the mainstay of oral anticoagulant therapy for more than 60 years (...) . The effectiveness of warfarin for the prevention of stroke in patients with atrial fibrillation is well established. In Canada, an estimated 200,000 to 250,000 people have this condition. Need for Recommendations Managing warfarin therapy is challenging because warfarin interacts with many foods and other drugs. Each patient needs an individualized warfarin dose, which takes time to determine and requires patients to go in for frequent laboratory testing of their blood to monitor

CADTH - Optimal Use2015

293. Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical Evidence

Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical Evidence Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical Evidence | CADTH.ca Find the information you need Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical (...) Evidence Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical Evidence Published on: August 20, 2012 Product Line: , CADTH Technology Overviews Issue: Volume 2, Issue 3 Result type: Report Adapted from . [Optimal Use Report; Volume 1, Issue 2A]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2011. For more information on this project, visit Introduction Atrial fibrillation (AF) is the most common

CADTH - Health Technology Assessment2015

294. Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical Evidence

Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical Evidence Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical Evidence | CADTH.ca Find the information you need Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical (...) Evidence Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: A Systematic Review of the Clinical Evidence Published on: August 20, 2012 Product Line: , CADTH Technology Overviews Issue: Volume 2, Issue 3 Result type: Report Adapted from . [Optimal Use Report; Volume 1, Issue 2A]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2011. For more information on this project, visit Introduction Atrial fibrillation (AF) is the most common

CADTH - Health Technology Assessment2015

295. Antithrombotic Agents for the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation

Antithrombotic Agents for the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation Antithrombotic Agents for the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation | CADTH.ca Find the information you need Antithrombotic Agents for the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation Antithrombotic Agents for the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation Published on: June (...) 28, 2013 Product Line: , CADTH Technology Overviews Issue: Volume 3, Issue 2 Result type: Report Adapted from Canadian Agency for Drugs and Technologies in Health. (Therapeutic Review) . Ottawa: Canadian Agency for Drugs and Technologies in Health; 2013. For more information on this project, visit Introduction Atrial fibrillation (AF) is a common cardiac arrhythmia associated with increased morbidity and mortality. 1,2 Patients with AF are at increased risk of stroke and systemic embolism (SSE

CADTH - Health Technology Assessment2015

296. Antithrombotic Therapy for Patients with Atrial Fibrillation

Antithrombotic Therapy for Patients with Atrial Fibrillation Antithrombotic Therapy for Patients with Atrial Fibrillation | CADTH.ca Find the information you need Antithrombotic Therapy for Patients with Atrial Fibrillation Antithrombotic Therapy for Patients with Atrial Fibrillation Published on: June 28, 2012 Project Number: TR0003 Product Line: Therapeutic Review Result type: Report CADTH previously reviewed the and the for patients with atrial fibrillation. The Antithrombotic Therapy (...) for Patients With Atrial Fibrillation project was an extension of the previous review of new oral anticoagulants, and it assessed all antithrombotic drugs currently used to prevent stroke in patients with atrial fibrillation: antiplatelet drugs such as acetylsalicylic acid (ASA) and clopidogrel anticoagulant drugs such as warfarin, dabigatran, rivaroxaban, and apixaban. Tools The Canadian Agency for Drugs and Technologies in Health (CADTH) developed the following tools to help transition our

CADTH - Therapeutic Review2015

297. Ablation Procedures for Rhythm Control in Patients With Atrial Fibrillation: Clinical and Cost-Effectiveness Analyses

Ablation Procedures for Rhythm Control in Patients With Atrial Fibrillation: Clinical and Cost-Effectiveness Analyses Ablation Procedures for Rhythm Control in Patients With Atrial Fibrillation: Clinical and Cost-Effectiveness Analyses | CADTH.ca Find the information you need Ablation Procedures for Rhythm Control in Patients With Atrial Fibrillation: Clinical and Cost-Effectiveness Analyses Ablation Procedures for Rhythm Control in Patients With Atrial Fibrillation: Clinical and Cost (...) -Effectiveness Analyses Published on: September 17, 2010 Product Line: Result type: Report Atrial fibrillation (AF) is a type of heart rhythm disturbance or arrhythmia that affects over 200,000 Canadians, including more than 5% of the population over the age of 65. The most common type of arrhythmia, AF is associated with a high degree of morbidity and mortality, including an increased risk of stroke. First-line therapy for AF is antiarrhythmic drugs (AADs), which are used to either terminate the arrhythmia

CADTH - Health Technology Assessment2015

298. Surgical Ablation for Atrial Fibrillation.

Surgical Ablation for Atrial Fibrillation. Surgical Ablation for Atrial Fibrillation. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26222570 Format MeSH and Other Data E-mail Subject Additional text E-mail (...) Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Jul 30;373(5):484. doi: 10.1056/NEJMc1506893. Surgical Ablation for Atrial Fibrillation. , , . Comment on [N Engl J Med. 2015] [N Engl J Med. 2015] [N Engl J Med. 2015] PMID: 26222570 DOI: [Indexed for MEDLINE] Free full text Publication types MeSH terms Grant support Full Text Sources Medical PubMed Commons 0 comments How to cite

NEJM2015 Full Text: Link to full Text with Trip Pro

299. Surgical Ablation for Atrial Fibrillation.

Surgical Ablation for Atrial Fibrillation. Surgical Ablation for Atrial Fibrillation. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26222571 Format MeSH and Other Data E-mail Subject Additional text E-mail (...) Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Jul 30;373(5):483. doi: 10.1056/NEJMc1506893#SA1. Surgical Ablation for Atrial Fibrillation. . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26222571 DOI: [Indexed for MEDLINE] Publication types MeSH terms Full Text Sources Medical PubMed Commons 0 comments How to cite this comment: Supplemental Content Full text

NEJM2015 Full Text: Link to full Text with Trip Pro

300. Surgical Ablation for Atrial Fibrillation.

Surgical Ablation for Atrial Fibrillation. Surgical Ablation for Atrial Fibrillation. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26222572 Format MeSH and Other Data E-mail Subject Additional text E-mail (...) Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Jul 30;373(5):483. doi: 10.1056/NEJMc1506893#SA2. Surgical Ablation for Atrial Fibrillation. , , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26222572 DOI: [Indexed for MEDLINE] Publication types MeSH terms Full Text Sources Medical PubMed Commons 0 comments How to cite this comment: Supplemental Content Full text

NEJM2015 Full Text: Link to full Text with Trip Pro